Remedies in Health Care Mergers Structure vs Behav
12:00 PM - 1:30 PM ET
Traditionally, enforcement agencies have had a preference for structural remedies in mergers. But behavioral remedies are becoming more popular, particularly in health care markets, and not just in consummated deals. Join us as we discuss questions such as: What are the advantages and disadvantages of behavioral remedies? Do policies encouraging larger, integrated provider arrangements prompt increased consideration of behavioral remedies? How have behavioral remedies worked in cases like Evanston?
• Lauren Rackow, Cahill Gordon & Reindel LLP, New York, NY
• Norman Armstrong, Federal Trade Commission, Washington, D.C.
• Elinor R. Hoffmann, Office of the New York State Attorney General, New York, NY
• Robert F. Leibenluft, Hogan Lovells, Washington, D.C.
• Sean May, Charles Rivers Associates, Boston, MA
CLE: The ABA is not seeking CLE Credit for this program.
FREE: Antitrust Section Members, Government, Nonprofit Employees and Students
$25.00: Other non-members